Prognostic implications of acute upper gastrointestinal graft-versus-host disease in patients undergoing myeloablative hematopoietic cell transplantation.
Study #: GV12-02
Study Status: Published
Upper gastrointestinal acute graft- versus-host disease adds minimal prognostic value in isolation or with other graft- versus-host disease symptoms as currently diagnosed and treated.
Nikiforow S, Wang T, Hemmer M, Spellman S, Akpek G, Antin JH, Choi SW, Inamoto Y, Khoury HJ, MacMillan M, Marks DI, Meehan K, Nakasone H, Nishihori T, Olsson R, Paczesny S, Przepiorka D, Reddy V, Reshef R, Schoemans H, Waller N, Weisdorf D, Wirk B, Horowitz M, Alousi A, Couriel D, Pidala J, Arora M, Cutler C.
Haematologica. 2018, Oct 01: 103(10): 103(10):1708-1719. doi: 10.3324/haematol.2017.182550. Epub 2018, Aug 03. PMCID:PMC6165812.
PMID: 30076185
Abstract